Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia
D. Maccubbin; H. E. Bays; A. G. Olsson; V. Elinoff; A. Elis; Y. Mitchel; W. Sirah; A. Betteridge; R. Reyes; Q. Yu; O. Kuznetsova; C. McCrary Sisk; R. C. Pasternak; J. F. Paolini
- 作者D. Maccubbin; H. E. Bays; A. G. Olsson; V. Elinoff; A. Elis; Y. Mitchel; W. Sirah; A. Betteridge; R. Reyes; Q. Yu; O. Kuznetsova; C. McCrary Sisk; R. C. Pasternak; J. F. Paolini
- 卷第62卷
- 期第12期
- 印刷ISSN1368-5031
- 电子ISSN1742-1241
- 文件大小334.28KB
- 发表时间2008
- DOI10.1111/j.1742-1241.2008.01938.x
- 页码1959-1970